Metabolically healthy obesity: facts and fantasies

Although obesity is typically associated with metabolic dysfunction and cardiometabolic diseases, some people with obesity are protected from many of the adverse metabolic effects of excess body fat and are considered "metabolically healthy." However, there is no universally accepted defin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical investigation 2019-10, Vol.129 (10), p.3978-3989
Hauptverfasser: Smith, Gordon I, Mittendorfer, Bettina, Klein, Samuel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3989
container_issue 10
container_start_page 3978
container_title The Journal of clinical investigation
container_volume 129
creator Smith, Gordon I
Mittendorfer, Bettina
Klein, Samuel
description Although obesity is typically associated with metabolic dysfunction and cardiometabolic diseases, some people with obesity are protected from many of the adverse metabolic effects of excess body fat and are considered "metabolically healthy." However, there is no universally accepted definition of metabolically healthy obesity (MHO). Most studies define MHO as having either 0, 1, or 2 metabolic syndrome components, whereas many others define MHO using the homeostasis model assessment of insulin resistance (HOMA-IR). Therefore, numerous people reported as having MHO are not metabolically healthy, but simply have fewer metabolic abnormalities than those with metabolically unhealthy obesity (MUO). Nonetheless, a small subset of people with obesity have a normal HOMA-IR and no metabolic syndrome components. The mechanism(s) responsible for the divergent effects of obesity on metabolic health is not clear, but studies conducted in rodent models suggest that differences in adipose tissue biology in response to weight gain can cause or prevent systemic metabolic dysfunction. In this article, we review the definition, stability over time, and clinical outcomes of MHO, and discuss the potential factors that could explain differences in metabolic health in people with MHO and MUO - specifically, modifiable lifestyle factors and adipose tissue biology. Better understanding of the factors that distinguish people with MHO and MUO can produce new insights into mechanism(s) responsible for obesity-related metabolic dysfunction and disease.
doi_str_mv 10.1172/JCI129186
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6763224</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A605723042</galeid><sourcerecordid>A605723042</sourcerecordid><originalsourceid>FETCH-LOGICAL-c713t-1246b986a84d825cc78cafc59cf766f12b598432eac8500cfe77cdd1142e83ea3</originalsourceid><addsrcrecordid>eNqNkl1rFDEUhoModq1e-AdkQZD2Ymq-Jsl4IZTF6pZKwa_bkMmc2U3JJnWSKe6_N0vrslv2QnKRkDx5TsJ5EXpN8Bkhkr6_nM0JbYgST9CE1LWqFGXqKZpgTEnVSKaO0IuUbjAmnNf8OTpipKZcMDxB9Ctk00bvrPF-PV2C8Xm5nsYWksvrD9Pe2JymJnRlFbJJDtJL9Kw3PsGrh_kY_bz49GP2pbq6_jyfnV9VVhKWK1IqtI0SRvFO0dpaqazpbd3YXgrRE9rWjeKMgrGqxtj2IKXtOkI4BcXAsGP08d57O7Yr6CyEPBivbwe3MsNaR-P0_klwS72Id1pIwSjlRXDyIBji7xFS1iuXLHhvAsQxaUob3Ahc8w369hF6E8chlO9pyjAjggu1Qy2MB-1CH0tdu5Hq8-KRBeW0UNUBagEByiNjgN6V7T3-7ABfRgcrZw9eON27UJgMf_LCjCnp-fdv_89e_9pn3-2w91FI0Y_ZxZAOSu0QUxqg3zaFYL1JpN4msrBvdru4Jf9FkP0FM-zVcA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2303164684</pqid></control><display><type>article</type><title>Metabolically healthy obesity: facts and fantasies</title><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Smith, Gordon I ; Mittendorfer, Bettina ; Klein, Samuel</creator><creatorcontrib>Smith, Gordon I ; Mittendorfer, Bettina ; Klein, Samuel</creatorcontrib><description>Although obesity is typically associated with metabolic dysfunction and cardiometabolic diseases, some people with obesity are protected from many of the adverse metabolic effects of excess body fat and are considered "metabolically healthy." However, there is no universally accepted definition of metabolically healthy obesity (MHO). Most studies define MHO as having either 0, 1, or 2 metabolic syndrome components, whereas many others define MHO using the homeostasis model assessment of insulin resistance (HOMA-IR). Therefore, numerous people reported as having MHO are not metabolically healthy, but simply have fewer metabolic abnormalities than those with metabolically unhealthy obesity (MUO). Nonetheless, a small subset of people with obesity have a normal HOMA-IR and no metabolic syndrome components. The mechanism(s) responsible for the divergent effects of obesity on metabolic health is not clear, but studies conducted in rodent models suggest that differences in adipose tissue biology in response to weight gain can cause or prevent systemic metabolic dysfunction. In this article, we review the definition, stability over time, and clinical outcomes of MHO, and discuss the potential factors that could explain differences in metabolic health in people with MHO and MUO - specifically, modifiable lifestyle factors and adipose tissue biology. Better understanding of the factors that distinguish people with MHO and MUO can produce new insights into mechanism(s) responsible for obesity-related metabolic dysfunction and disease.</description><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/JCI129186</identifier><identifier>PMID: 31524630</identifier><language>eng</language><publisher>United States: American Society for Clinical Investigation</publisher><subject>Adipose tissue ; Analysis ; Animal models ; Biomedical research ; Body fat ; Body weight gain ; Cholesterol ; Clinical outcomes ; Diabetes ; Glucose ; Heart ; Homeostasis ; Insulin ; Insulin resistance ; Metabolic syndrome ; Obesity ; Review Series ; Studies ; Type 2 diabetes ; Womens health</subject><ispartof>The Journal of clinical investigation, 2019-10, Vol.129 (10), p.3978-3989</ispartof><rights>COPYRIGHT 2019 American Society for Clinical Investigation</rights><rights>Copyright American Society for Clinical Investigation Oct 2019</rights><rights>2019 American Society for Clinical Investigation 2019 American Society for Clinical Investigation</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c713t-1246b986a84d825cc78cafc59cf766f12b598432eac8500cfe77cdd1142e83ea3</citedby><cites>FETCH-LOGICAL-c713t-1246b986a84d825cc78cafc59cf766f12b598432eac8500cfe77cdd1142e83ea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763224/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763224/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31524630$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smith, Gordon I</creatorcontrib><creatorcontrib>Mittendorfer, Bettina</creatorcontrib><creatorcontrib>Klein, Samuel</creatorcontrib><title>Metabolically healthy obesity: facts and fantasies</title><title>The Journal of clinical investigation</title><addtitle>J Clin Invest</addtitle><description>Although obesity is typically associated with metabolic dysfunction and cardiometabolic diseases, some people with obesity are protected from many of the adverse metabolic effects of excess body fat and are considered "metabolically healthy." However, there is no universally accepted definition of metabolically healthy obesity (MHO). Most studies define MHO as having either 0, 1, or 2 metabolic syndrome components, whereas many others define MHO using the homeostasis model assessment of insulin resistance (HOMA-IR). Therefore, numerous people reported as having MHO are not metabolically healthy, but simply have fewer metabolic abnormalities than those with metabolically unhealthy obesity (MUO). Nonetheless, a small subset of people with obesity have a normal HOMA-IR and no metabolic syndrome components. The mechanism(s) responsible for the divergent effects of obesity on metabolic health is not clear, but studies conducted in rodent models suggest that differences in adipose tissue biology in response to weight gain can cause or prevent systemic metabolic dysfunction. In this article, we review the definition, stability over time, and clinical outcomes of MHO, and discuss the potential factors that could explain differences in metabolic health in people with MHO and MUO - specifically, modifiable lifestyle factors and adipose tissue biology. Better understanding of the factors that distinguish people with MHO and MUO can produce new insights into mechanism(s) responsible for obesity-related metabolic dysfunction and disease.</description><subject>Adipose tissue</subject><subject>Analysis</subject><subject>Animal models</subject><subject>Biomedical research</subject><subject>Body fat</subject><subject>Body weight gain</subject><subject>Cholesterol</subject><subject>Clinical outcomes</subject><subject>Diabetes</subject><subject>Glucose</subject><subject>Heart</subject><subject>Homeostasis</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>Metabolic syndrome</subject><subject>Obesity</subject><subject>Review Series</subject><subject>Studies</subject><subject>Type 2 diabetes</subject><subject>Womens health</subject><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkl1rFDEUhoModq1e-AdkQZD2Ymq-Jsl4IZTF6pZKwa_bkMmc2U3JJnWSKe6_N0vrslv2QnKRkDx5TsJ5EXpN8Bkhkr6_nM0JbYgST9CE1LWqFGXqKZpgTEnVSKaO0IuUbjAmnNf8OTpipKZcMDxB9Ctk00bvrPF-PV2C8Xm5nsYWksvrD9Pe2JymJnRlFbJJDtJL9Kw3PsGrh_kY_bz49GP2pbq6_jyfnV9VVhKWK1IqtI0SRvFO0dpaqazpbd3YXgrRE9rWjeKMgrGqxtj2IKXtOkI4BcXAsGP08d57O7Yr6CyEPBivbwe3MsNaR-P0_klwS72Id1pIwSjlRXDyIBji7xFS1iuXLHhvAsQxaUob3Ahc8w369hF6E8chlO9pyjAjggu1Qy2MB-1CH0tdu5Hq8-KRBeW0UNUBagEByiNjgN6V7T3-7ABfRgcrZw9eON27UJgMf_LCjCnp-fdv_89e_9pn3-2w91FI0Y_ZxZAOSu0QUxqg3zaFYL1JpN4msrBvdru4Jf9FkP0FM-zVcA</recordid><startdate>20191001</startdate><enddate>20191001</enddate><creator>Smith, Gordon I</creator><creator>Mittendorfer, Bettina</creator><creator>Klein, Samuel</creator><general>American Society for Clinical Investigation</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20191001</creationdate><title>Metabolically healthy obesity: facts and fantasies</title><author>Smith, Gordon I ; Mittendorfer, Bettina ; Klein, Samuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c713t-1246b986a84d825cc78cafc59cf766f12b598432eac8500cfe77cdd1142e83ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adipose tissue</topic><topic>Analysis</topic><topic>Animal models</topic><topic>Biomedical research</topic><topic>Body fat</topic><topic>Body weight gain</topic><topic>Cholesterol</topic><topic>Clinical outcomes</topic><topic>Diabetes</topic><topic>Glucose</topic><topic>Heart</topic><topic>Homeostasis</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>Metabolic syndrome</topic><topic>Obesity</topic><topic>Review Series</topic><topic>Studies</topic><topic>Type 2 diabetes</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smith, Gordon I</creatorcontrib><creatorcontrib>Mittendorfer, Bettina</creatorcontrib><creatorcontrib>Klein, Samuel</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale in Context : Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smith, Gordon I</au><au>Mittendorfer, Bettina</au><au>Klein, Samuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolically healthy obesity: facts and fantasies</atitle><jtitle>The Journal of clinical investigation</jtitle><addtitle>J Clin Invest</addtitle><date>2019-10-01</date><risdate>2019</risdate><volume>129</volume><issue>10</issue><spage>3978</spage><epage>3989</epage><pages>3978-3989</pages><issn>0021-9738</issn><eissn>1558-8238</eissn><abstract>Although obesity is typically associated with metabolic dysfunction and cardiometabolic diseases, some people with obesity are protected from many of the adverse metabolic effects of excess body fat and are considered "metabolically healthy." However, there is no universally accepted definition of metabolically healthy obesity (MHO). Most studies define MHO as having either 0, 1, or 2 metabolic syndrome components, whereas many others define MHO using the homeostasis model assessment of insulin resistance (HOMA-IR). Therefore, numerous people reported as having MHO are not metabolically healthy, but simply have fewer metabolic abnormalities than those with metabolically unhealthy obesity (MUO). Nonetheless, a small subset of people with obesity have a normal HOMA-IR and no metabolic syndrome components. The mechanism(s) responsible for the divergent effects of obesity on metabolic health is not clear, but studies conducted in rodent models suggest that differences in adipose tissue biology in response to weight gain can cause or prevent systemic metabolic dysfunction. In this article, we review the definition, stability over time, and clinical outcomes of MHO, and discuss the potential factors that could explain differences in metabolic health in people with MHO and MUO - specifically, modifiable lifestyle factors and adipose tissue biology. Better understanding of the factors that distinguish people with MHO and MUO can produce new insights into mechanism(s) responsible for obesity-related metabolic dysfunction and disease.</abstract><cop>United States</cop><pub>American Society for Clinical Investigation</pub><pmid>31524630</pmid><doi>10.1172/JCI129186</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9738
ispartof The Journal of clinical investigation, 2019-10, Vol.129 (10), p.3978-3989
issn 0021-9738
1558-8238
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6763224
source PubMed Central; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects Adipose tissue
Analysis
Animal models
Biomedical research
Body fat
Body weight gain
Cholesterol
Clinical outcomes
Diabetes
Glucose
Heart
Homeostasis
Insulin
Insulin resistance
Metabolic syndrome
Obesity
Review Series
Studies
Type 2 diabetes
Womens health
title Metabolically healthy obesity: facts and fantasies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T15%3A41%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolically%20healthy%20obesity:%20facts%20and%20fantasies&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Smith,%20Gordon%20I&rft.date=2019-10-01&rft.volume=129&rft.issue=10&rft.spage=3978&rft.epage=3989&rft.pages=3978-3989&rft.issn=0021-9738&rft.eissn=1558-8238&rft_id=info:doi/10.1172/JCI129186&rft_dat=%3Cgale_pubme%3EA605723042%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2303164684&rft_id=info:pmid/31524630&rft_galeid=A605723042&rfr_iscdi=true